Loading...
Symbols:
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
Transcripts
- IntegraMed America, Inc. Q3 2008 Earnings Call Transcript
- Cell Genesys, Inc. Q3 2008 Earnings Call Transcript
- Columbia Laboratories, Inc. Q3 2008 Earnings Call Transcript
- Pacific Sunwear F3Q08 (Qtr End 11/1/08) Earnings Call Transcript
- Mad Catz Interactive, Inc. F2Q09 (Qtr End 09/30/2008) Earnings Call Transcript
- Provectus Pharmaceuticals, Inc. The Wall Street Analyst Forum Call Transcript
- Point Blank Solutions, Inc. Q3 2008 (Quarter End 9/30/08) Earnings Call Transcript
- Navios Maritime Holdings Inc., Q3 2008 Earnings Call Transcript
- Gran Tierra Energy Inc. Q3 2008 (Qtr End 09/30/08) Earnings Call Transcript
- Oxygen Biotherapeutics, Inc. The Wall Street Analyst Forum Call Transcript
-
Editors' Picks
-
Most Popular
- My Reconsideration: Why Share Buybacks Are Pointless
- GM Could Benefit from Bankruptcy
- Throwing in the Towel on This Market?
- General Electric: Genuine Risk of Collapse?
- Food: Against Self-Sufficiency
- The Fed: Now the World's Largest Private Bank
- Full list of Editors' Picks »
- General Electric: Genuine Risk of Collapse? »
- Memo to Warren: AmEx Preferred at 15%, Warrants at $12 »
- Peak Oil's Bell Is Ringing »
- Should We Really Bail Out the Big Three Automakers with $73.20 Per Hour Labor? »
- The Pickens Plan Changes Its Strategy »
- Jim Rogers on China »
- Thornburg Mortgage, Inc. The Wall Street Analyst Call Transcript »
- The Biggest Problem Detroit's Big Three Face »
- Tech May Be a Wreck, But This Isn't 2001 »
- Wall Street Breakfast: Must-Know News »
- Precious Metals Will Depose Cash from Its Temporary Throne »
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
Stanlan
2 Comments
Andy Grove: Rich, Famous, Smart and Wrong About Drugmakers
If my hard drive crashes, it sucks but I'll live.
Not necessarily the case if the medication I'm taking fails me.
4 Reasons Amgen Looks Anemic
They're pipeline is fairly extensive, Denosumab being the most promising agent with blockbuster potential.
Slowing revenue growth? Let's not forget, the population is aging, not getting any younger, the baby boomer onslaught is at its very beginning. The incidence of diabetes is increasing, along with its complications such as end stage renal disease.
Epogen and Aranesp are not going away and will continue to drive revenues for now. - other than Procrit (which is basically Epogen), there is NO ALTERNATIVE. This is a company whose drugs are needed now more than when they were first introduced.
Amgen doesnt need to do a whole lot to increase shareholder value other than trek on as it is. Revenues will remain steady and gradual increase, eroding the current uncertainty that surrounds the stock, and allowing share value to increase.